Chemours is trading 4.95% lower at $14.01 as higher Treasury yields weigh on equity valuations.

  • No company-specific announcement or earnings catalyst was identified for September 24, 2026.
  • The decline is occurring despite Materials-sector strength, making sector weakness an unlikely explanation.
  • The Nasdaq is down 0.89% and the S&P 500 is down 0.48% amid broader risk-off sentiment.